USPTO serial 78943026
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bingham B. Leverich, Esq.
BINGHAM B LEVERICH ESQ COVINGTON & BURLING LLP1201 PENNSYLVANIA AVE NWWASHINGTON, DC 20004-2401UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations for use in the treatment of high cholesterol, cardiovascular diseases, and diabetes | ABANDONED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 7, 2007 | MAB5 | ABANDONMENT NOTICE MAILED - AFTER PUBLICATION | — |
| Aug 7, 2007 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Aug 3, 2007 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Jun 20, 2007 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Apr 11, 2007 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Mar 20, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 28, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Jan 31, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 31, 2007 | ALIE | ASSIGNED TO LIE | — |
| Dec 28, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 27, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 8, 2006 | NWAP | NEW APPLICATION ENTERED | — |